MedPath

Trial of the Effect of Thiazides on Normotensive Individuals in China

Not Applicable
Conditions
Cardiovascular disease
Circulatory System
Prevention of cardiovascular disease
Registration Number
ISRCTN21115645
Lead Sponsor
The University of Birmingham, Birmingham (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped
Sex
All
Target Recruitment
0
Inclusion Criteria

The eligible population for this pilot will include men and women between the ages of 60 and 75 (inclusive) living in Guangzhou, who attend for an ongoing cohort study, and are found to be normotensive.

Exclusion Criteria

People with existing vascular disease, clear indication or contra-indication for antihypertensive treatment and diuretics, and other chronic medical problems that would interfere with participation will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ot provided at time of registration
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath